Literature DB >> 21987435

Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis.

Stijn Keereweer1, Jeroen D F Kerrebijn, Isabel M Mol, J Sven D Mieog, Pieter B A A Van Driel, Robert J Baatenburg de Jong, Alexander L Vahrmeijer, Clemens W G M Löwik.   

Abstract

BACKGROUND: In oral cancer surgery, intraoperative optical imaging could help the surgeon to determine adequate tumor-free margins.
METHODS: Tumor-specific near-infrared fluorescence agents targeting epidermal growth factor receptor (CW800 EGF) or glucose transporter system (CW800 2-DG) were administered to mice with tongue carcinoma and cervical lymph node metastases. Tumor growth was followed by bioluminescence imaging. Fluorescence signals were compared with a control group of healthy animals.
RESULTS: Significantly higher fluorescence was found in tongue tumors and cervical lymph node metastases compared with that in control animals. Fluorescence correlated with histopathology. Tumor-to-background ratio of CW800 EGF in the tongue was 13.8 (SD = 6.1) and in the lymph nodes 15.7 (SD = 8.8). For CW800 2-DG, the tumor-to-background ratio in the tongue was 4.6 (SD = 2.1) and in the lymph nodes 33.9 (SD = 18.4).
CONCLUSIONS: Optical imaging can be used to detect oral cancer and cervical lymph node metastases and could potentially improve complete surgical resection by real-time image-guided surgery.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21987435     DOI: 10.1002/hed.21861

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  18 in total

Review 1.  Molecular margins in head and neck cancer: Current techniques and future directions.

Authors:  Katelyn O Stepan; Michael M Li; Stephen Y Kang; Sidharth V Puram
Journal:  Oral Oncol       Date:  2020-07-20       Impact factor: 5.337

Review 2.  Role of near-infrared fluorescence imaging in head and neck cancer surgery: from animal models to humans.

Authors:  Ihab Atallah; Clément Milet; Jean-Luc Coll; Emile Reyt; Christian Adrien Righini; Amandine Hurbin
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-13       Impact factor: 2.503

3.  Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma.

Authors:  Kristine E Day; Lauren N Beck; C Hope Heath; Conway C Huang; Kurt R Zinn; Eben L Rosenthal
Journal:  Cancer Biol Ther       Date:  2013-01-08       Impact factor: 4.742

4.  Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.

Authors:  Larissa Sweeny; Andrew Prince; Neel Patel; Lindsay S Moore; Eben L Rosenthal; Brian B Hughley; Jason M Warram
Journal:  Laryngoscope       Date:  2016-08-31       Impact factor: 3.325

5.  Polychromatic in vivo imaging of multiple targets using visible and near infrared light.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Peter L Choyke
Journal:  Adv Drug Deliv Rev       Date:  2012-12-07       Impact factor: 15.470

6.  Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.

Authors:  Kristine E Day; Lauren N Beck; Nicholas L Deep; Joy Kovar; Kurt R Zinn; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2013-04-24       Impact factor: 3.325

7.  Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.

Authors:  Kristine E Day; Larissa Sweeny; Brian Kulbersh; Kurt R Zinn; Eben L Rosenthal
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

Review 8.  Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2018-08-06       Impact factor: 3.454

Review 9.  Margin Analysis in Head and Neck Cancer: State of the Art and Future Directions.

Authors:  Michael M Li; Sidharth V Puram; Dustin A Silverman; Matthew O Old; James W Rocco; Stephen Y Kang
Journal:  Ann Surg Oncol       Date:  2019-08-05       Impact factor: 5.344

10.  Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.

Authors:  P B A A van Driel; J R van der Vorst; F P R Verbeek; S Oliveira; T J A Snoeks; S Keereweer; B Chan; M C Boonstra; J V Frangioni; P M P van Bergen en Henegouwen; A L Vahrmeijer; C W G M Lowik
Journal:  Int J Cancer       Date:  2013-12-12       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.